Embassy Suites by Hilton Boulder Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

NOTES:
This meeting occurs in 2021.
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


Download Flyer

Twitter hashtag for this meeting: #KSneurotreatment21

Neuropsychiatric and Neurodevelopmental Disorders: Harnessing Rare Variants for Diagnosis and Treatment (A3)

Scientific Organizers: Jennifer G. Mulle, Audrey Thurm, Christa L. Martin and Carrie E. Bearden


January 24—27, 2021

Embassy Suites by Hilton Boulder, Boulder, Colorado, USA


Supported by the Directors' Fund


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

** Registration opens in January 2020 **



Discounted Abstract Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is )

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is )

Discounted Registration Deadline: November 23, 2020

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, January 24 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, January 27 with a closing plenary session from 14:30 to 19:00, followed by a social hour and entertainment. We recommend return travel on Thursday, January 28 in order to fully experience the meeting.

SUNDAY, JANUARY 24

16:00—20:00
Arrival and Registration

18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


MONDAY, JANUARY 25

07:00—08:00
Breakfast

08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 12/24/2020

Matt Might†, University of Alabama at Birmingham, USA
A Rare Genetic Syndrome from the Patient Perspective

09:00—11:30
CNV Disorders
Registered attendees can view abstracts starting on 12/24/2020
A selection of CNV disorders and the phenotypes that are associated with them, and headway into mechanism. What are the challenges?

Raquel E. Gur, University of Pennsylvania, USA
22q11.2 Deletion and/or 22q11.2 Duplication

Jennifer G. Mulle, Emory University School of Medicine, USA
3q29 Deletion and 3q29 Duplication

Wendy K. Chung, Columbia University, USA
Deep Dive into 16p11.2 Deletion and Duplication

Short Talks Chosen from Abstracts

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Roundtable Discussion 1: Different RGDs (Rare Genetic Disorders) and the Differences/Similarities Between Them

16:30—17:00
Coffee Available

17:00—19:00
Single Gene Disorders
Registered attendees can view abstracts starting on 12/24/2020
A focus on single gene disorders associated with neurodevelopment and neuropsychiatric illness.

Huda Y. Zoghbi†, HHMI/Baylor College of Medicine, USA
Rett Syndrome

Stephan Sanders, University of California, San Francisco, USA
Phenotypes, Biology, and Therapeutic Strategies for SCN2A

Speaker to be Announced

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


TUESDAY, JANUARY 26

07:00—08:00
Breakfast

08:00—11:00
How Do We Measure Phenotypes? How Do We Harmonize across Studies?
Registered attendees can view abstracts starting on 12/24/2020
To understand the tools we have, the existing state of research, and the gaps that need to be addressed to enable cross-disorder comparison.

Christa L. Martin, Geisinger Health, USA
Population Genomic Screening for Brain Disorders

Audrey Thurm, NIMH, National Institutes of Health, USA
Harmonization of Phenotypes

Coffee Break

Elise Robinson, Harvard T.H. Chan School of Public Health and Broad Institute, USA
The NeuroDev Study: Phenotyping in African Populations

Sébastien Jacquemont, University of Montreal, Canada
Mapping the Effect of CNVs Genome-Wide on Cognition, Brain Structure and Functional Connectivity

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Roundtable Discussion 2: What the Outstanding Questions are and What Tools are Needed to Answer Them?

16:30—17:00
Coffee Available

17:00—19:00
Mechanistic Studies of RGDs
Registered attendees can view abstracts starting on 12/24/2020
Molecular and cellular mechanisms of disease can reveal insights toward management and treatment. This session is designed to highlight successes and stories in progress of research toward mechanism.

Lucy Osborne, University of Toronto, Canada
Mechanistic Studies of 7q11.23 Copy Number Variation

Thomas Bourgeron, Institut Pasteur, France
Functional Impact of Autism-Associated Mutations

Maria Chahrour, University of Texas Southwestern Medical Center, USA
Neurodevelopmental Disorders: From Genetics to Mechanisms

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 2


WEDNESDAY, JANUARY 27

07:00—08:00
Breakfast

08:00—11:00
Convergent Biology and Translation to Idiopathic Disease
Registered attendees can view abstracts starting on 12/24/2020
The promise of rare genetic disorders is that they may reveal mechanisms that are generalizable to common disorders. What is the evidence for that? What tools do we have?

Carrie E. Bearden, University of California Los Angeles, USA
Talk Title to be Announced

Nenad Sestan, Yale School of Medicine, USA
Tools to Identify Convergent Biology

Coffee Break

Armin Raznahan, NIMH, National Institutes of Health, USA
Genetics First Approaches and Childhood Onset Neuropsychiatric Disease

Daniel H. Geschwind†, University of California, Los Angeles, USA
Convergent Biology

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:30—16:30
How Do We Get to Treatment?
Registered attendees can view abstracts starting on 12/24/2020

Randall L. Carpenter, Rett Syndrome Research Trust, USA
When Clinical Trials Fail: A Post-Mortem

Ricardo E. Dolmetsch†, Novartis Institutes for BioMedical Research, USA
What Tools do we need to Develop Effective Treatments?

Mustafa Sahin, Boston Children's Hospital, USA
Clinical Trials and TSC

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—18:45
Panel Discussion: How Do RGD Fit within the NIH Mission?
Registered attendees can view abstracts starting on 12/24/2020
The research priorities of different NIH institutes influence how we advance. As disorders cross boundaries in phenotype, they also cross NIH institute boundaries. What is the NIH perspective on the future of this work?

Speaker to be Announced

Speaker to be Announced

Speaker to be Announced

Short Talks Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/24/2020

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.


THURSDAY, JANUARY 28

 
Departure


*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Corporate Relations, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org,
Phone:+1 970-262-1179